Independent · Mechanism-First · Evidence-Graded

Measslainte

Clearance, tolerance, and recovery in chronic illness

Independent research on chronic post-viral and post-vaccination illness. The clearance-and-tolerance framework, pathway mechanics, stratified biomarkers, and the natural compounds that act as levers within it.

Latest Research

Investigations into natural compounds, cellular health mechanisms, and evidence-based wellness protocols.

Featured: The Spikeopathy Research Cluster

The most developed work on this site. A unified framework for chronic spike-related illness as systemic clearance and tolerance failure under persistent antigenic drive: pathway mechanics (mTOR, glymphatic, SIRT1), five mechanistic subtypes, a tiered biomarker matrix, and intervention protocols. Evidence-graded, primary-source, falsifiable.

Enter the cluster   Read the flagship

Senate Homeland Security & Governmental Affairs Committee (SHSGAC) COVID-19 oversight document page marked UNCLASSIFIED / For SHSGAC Use Only, referencing mRNA vaccine findings.

Pinsolle's Framework: Spike, mRNA, and the Lab-Origin Question

A write-up of Dr. Typhaine Pinsolle's integrated framework on the SARS-CoV-2 spike, the COVID mRNA injections, and the lab-origin question, with the strongest evidence stated loud, the speculative hedged, the counter-evidence engaged, and four retractions of invalid statistics preserved in place.

Measslainte: independent health research

Post-Pandemic Opportunistic Infections: Beyond Candida

A comprehensive clinical analysis of how COVID-19 disrupts immune function and microbiome balance, increasing susceptibility to secondary infections beyond common fungal pathogens, with special attention to emerging post-intervention syndromes.

Proteomic analysis of pathological clot composition

Beyond Blood Clots: PAD4, mRNA Technology, and the Calamari Thrombosis Hypothesis

Molecular analysis of unusual 'calamari clots' reveals connections between lipid nanoparticles, PAD4 citrullination, and treatment-resistant thrombosis. Limited human evidence; proteomic data from investigator reports requires validation.

SARS-CoV-2 proteins converging on MHC-I suppression, functional analogy to HIV Nef

HIV-Protein Functional Analogy in SARS-CoV-2

Declaration of Purpose This analysis promotes scientific transparency and informed consent. All data are cited from primary or peer-reviewed sources where available; expert reports and preprints are flagged as such. No medical advice is given; evidence is shared for public understanding. Claims carry evidence tags under the system documented on the Methodology page. This content is for educational purposes only. Not medical advice; consult healthcare providers before therapeutic use. TL;DR Core finding. Multiple SARS-CoV-2 proteins (ORF8, ORF7a, ORF3a, and the Omicron-era E mutation) suppress MHC-I, creating a functional analogy to HIV-1 Nef's immune-evasion outcome (not mechanistic identity). This is supported by peer-reviewed cell and structural studies. PP + MECHANISTIC · HIGH for the MHC-I downregulation claim itself. ...

Stylized niclosamide molecule on a dark grid with Measslainte branding

Niclosamide Repurposing: The 2025 Evidence Check

Niclosamide is established for tapeworm infection and now has RCT evidence in COVID-19 via a nanohybrid formulation. What that does, and does not, establish about antiparasitic repurposing, graded on 2025 trial data.

Black Seed Oil: Evidence-Based Benefits and Clinical Applications

Black Seed Oil: Evidence-Based Benefits and Clinical Applications

Evidence-graded review of black seed oil (Nigella sativa) benefits, incorporating recent meta-analyses and systematic reviews. Separates clinical proof from traditional use and emerging research.

DNA contamination research gaps

Critical Research Gaps: What We Still Don't Know About DNA Contamination

The fundamental questions that remain unanswered about DNA contamination, SV40 promoters, and long-term safety; questions that should have been resolved before mass deployment.

Historical medical documents and microscopy images showing century of spirochetal research with endothelial invasion patterns

SPED & Neurospirochetosis: Endothelial Invasion and a Century of Neglected Evidence

For over 100 years, evidence of spirochetal brain infection has been ignored. Now, the Spike Protein is using the same endothelial playbook. Here's the damning continuity.

Borrelia cystic forms under microscopy

Exploring the Link Between Neurospirochetosis, Lyme Disease (Borrelia burgdorferi) & Multiple Sclerosis (MS)

Uncover the hidden history of Lyme disease and its connection to MS, what the microscopes show, why tests miss it, and how to lower the inflammatory load now.

Fluorescence micrograph showing Thioflavin T-positive amyloid fibrils with green staining against dark background, demonstrating beta-sheet structures in blood sample

Amyloid Fibrin Microclots in Long COVID: Evidence Review and Treatment Landscape

Peer-reviewed evidence for spike-induced amyloid fibrin microclots in Long COVID, the diagnostic gap created by standard coagulation panels, and the treatment landscape. Investigator reports are separated from peer-reviewed work.

Visual representation of spike protein persistence mechanisms showing microclots, viral reactivation, and cellular dysfunction

Spike Persistence: Microclots, Reactivated Viruses, and Failed Clearance

Recent studies, including 2024-2025 work, indicate SARS-CoV-2 and its spike protein can persist for months, with links to immune changes, latent herpesvirus reactivation, and fibrin(ogen) amyloid microclots. These mechanisms may help explain features of Long COVID and some post-vaccination syndromes.

DNA sequencing graph showing bacterial methylation patterns and SV40 promoter sequences

mRNA Vaccine DNA Contamination: SV40 Promoter & Integration Risks

TL;DR The core finding: mRNA vaccines contain bacterial DNA with active SV40 promoter sequences: contamination confirmed by 9+ independent labs across four continents, with levels up to 627-fold above regulatory limits and 815-fold variance between batches. ...